Lv4
780 积分 2025-01-15 加入
Recent updates in the therapeutic uses of Pembrolizumab: a brief narrative review
2小时前
待确认
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review
2个月前
已完结
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
2个月前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
2个月前
已完结
East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians
3个月前
已完结
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
3个月前
已完结
The Effects of Race on Anti-PD-(L)1 Monoclonal Antibodies in Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis
3个月前
已完结
The Effects of Race on Anti-PD-(L)1 Monoclonal Antibodies in Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis
3个月前
已完结
Non-Small Cell Lung Cancer in Never-Smokers: A New Disease Entity?
3个月前
已完结
皖公网安备34019202002308
